Aging-associated shifts in functional status of mast cells located by adult and aged mesenteric lymphatic vessels

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 303, Issue 6, 2012, Pages

  Chatterjee, Victor ^a   Gashev, Anatoliy A ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Compound 48 80; Immunoglobulin E; Mast cells; Mesenteric lymphatic vessels; Peptidoglycan; Substance P

Indexed keywords

AVIDIN; COMPOUND 48-80; HISTAMINE; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E; MEMBRANE PROTEIN; MEMBRANE PROTEIN 16A; PEPTIDOGLYCAN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE D2; RUTHENIUM RED; STEM CELL FACTOR RECEPTOR; SUBSTANCE P; TOLONIUM CHLORIDE; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GROUPS BY AGE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPH VESSEL; MALE; MAST CELL; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULATION;

AGE FACTORS; AGING; ANIMALS; BIOLOGICAL MARKERS; CELLULAR MICROENVIRONMENT; CHLORIDE CHANNELS; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; LYMPHATIC VESSELS; MALE; MAST CELLS; MESENTERY; P-METHOXY-N-METHYLPHENETHYLAMINE; PEPTIDOGLYCAN; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, INBRED F344; STAINING AND LABELING; STAPHYLOCOCCUS AUREUS; SUBSTANCE P; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866386575     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00378.2012     Document Type: Article

References (75)

1. Akl TJ, Nagai T, Cote GL, Gashev AA. Mesenteric lymph flow in adult and aged rats. Am Physiol Heart Circ Physiol 301: H1828-H1840, 2011.
2. Amin K. The role of mast cells in allergic inflammation. Respir Med 106: 9-14, 2012.
3. Beil WJ, Schulz M, Wefelmeyer U. Mast cell granule composition and tissue location-a close correlation. Histol Histopathol 15: 937-946, 2000.
4. Benoit JN, Zawieja DC. Gastrointestinal lymphatics. In: Physiology of the gastrointestinal tract, edited by Johnson L. New York: Raven Press, 1994, p. 1669-1692.
5. Bergstresser PR, Tigelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 83: 214-218, 1984.
6. Bohn A, Konig W. Monoclonal murine anti-DNP IgE: in vitro histamine release of rat mast cells in the presence of reaginic rat and mouse sera. Agents Actions 16: 485-490, 1985.
7. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23: 15-39, 2003.
8. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 8: 131-136, 2001.
9. Bussolati G, Gugliotta P. Nonspecific staining of mast cells by avidinbiotin-peroxidase complexes (ABC). J Histochem Cytochem 31: 1419-1421, 1983.
10. Coleman JW, Huang Q, Stanworth DR. The mast cell response to substance P: effects of neuraminidase, limulin, and some novel synthetic peptide antagonists. Peptides 7: 171-175, 1986.
11. Columbo M, Horowitz EM, Kagey-Sobotka A, Lichtenstein LM. Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin Immunol Immunopath 81: 68-73, 1996.
12. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB 17: 1183-1185, 2003.
13. Dawicki W, Jawdat DW, Xu N, Marshall JS. Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol 184: 2116-2123, 2010.
14. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol 19: 31-38, 2007.
15. Dobbins DE. Receptor mechanisms of serotonin-induced prenodal lymphatic constriction in the canine forelimb. Am J Physiol Heart Circ Physiol 274: H650-H654, 1998.
16. Dobbins DE, Buehn MJ, Dabney JM. Constriction of perfused lymphatics by acetylcholine, bradykinin and histamine. Microcirc Endothelium Lymphatics 6: 409-425, 1990.
17. Ferguson MK, Shahinian HK, Michelassi F. Lymphatic smooth muscle responses to leukotrienes, histamine and platelet activating factor. J Surg Res 44: 172-177, 1988.
18. Fox JLR, von der Weid PY. Effects of histamine on the contractile and electrical activity in isolated lymphatic vessels of the guinea-pig mesentery. Br J Pharmacol 136: 1210-1218, 2002.
19. Gashev AA, Davis MJ. Long-distance transportation of live isolated lymphatic vessels. Lymphat Res Biol 8: 189-192, 2010.
20. Gashev AA, Davis MJ, Gasheva OY, Nepiushchikh ZV, Wang W, Dougherty P, Kelly KA, Cai S, von der Weid PY, Muthuchamy M, Meininger CJ, Zawieja DC. Methods for lymphatic vessel culture and gene transfection. Microcirculation 16: 615-628, 2009.
21. Gasheva OY, Knippa K, Nepiushchikh ZV, Muthuchamy M, Gashev AA. Age-related alterations of active pumping mechanisms in rat thoracic duct. Microcirculation 14: 827-839, 2007.
22. Ghannadan M, Baghestanian M, Wimazal F, Eisenmenger M, Latal D, Kargul G, Walchshofer S, Sillaber C, Lechner K, Valent P. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 111: 689-695, 1998.
23. Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol 17: 457-462, 2005.
24. Gomez CR, Nomellini V, Faunce DE, Kovacs EJ. Innate immunity and aging. Exp Gerontol 43: 718-728, 2008.
25. Gunin AG, Kornilova NK, Vasilieva OV, Petrov VV. Age-related changes in proliferation, the numbers of mast cells, eosinophils, and cd45-positive cells in human dermis. J Gerontol A Biol Sci Med Sci 66: 385-392, 2011.
26. Hart PH, Grimbaldeston MA, Hosszu EK, Swift GJ, Noonan FP, Finlay-Jones JJ. Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of Kit. Immunology 98: 352-356, 1999.
27. Harvima IT, Nilsson G. Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol 91: 644-650, 2011.
28. Heib V, Becker M, Warger T, Rechtsteiner G, Tertilt C, Klein M, Bopp T, Taube C, Schild H, Schmitt E, Stassen M. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 110: 946-953, 2007.
29. Horsfield GI. The effect of compound 48/80 on the rat mast cell. J Pathol 90: 599-605, 1965.
30. Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS. IgEmediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 173: 5275-5282, 2004.
31. Jawdat DM, Rowden G, Marshall JS. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 177: 1755-1762, 2006.
32. Johnston MG, Kanalec A, Gordon JL. Effects of arachidonic acid and its cyclo-oxygenase and lipoxygenase products on lymphatic vessel contractility in vitro. Prostaglandins 25: 85-98, 1983.
33. Kirshenbaum AS, Swindle E, Kulka M, Wu Y, Metcalfe DD. Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokine production, and protease composition. BMC Immunol 9: 45, 2008.
34. Kluth W. [The presence of mast cells in the thoracic duct.] Zentralbl Allg Pathol 87: 139-141, 1951.
35. Kruger PG, Bloom GD. Structural features of histamine release in rat peritoneal mast cells. A study with toluidine blue. Int Arch Allergy Appl Immunol 46: 740-752, 1974.
36. Kubes P. Ruthenium red as measure of mast cell activation. Methods Enzymol 301: 22-27, 1999.
37. Kubes P, Gaboury JP. Rapid mast cell activation causes leukocytedependent and-independent permeability alterations. Am J Physiol Heart Circ Physiol 271: H2438-H2446, 1996.
38. Lagunoff D. Vital staining of mast cells with ruthenium red. J Histochem Cytochem 20: 938-944, 1972.
39. Lobov GI, Pan'kova MN. Heparin inhibits contraction of smooth muscle cells in lymphatic vessels. Bull Exp Biol Med 149: 4-6, 2010.
40. Malaviya R, Abraham SN. Mast cell modulation of immune responses to bacteria. Immunol Rev 179: 16-24, 2001.
41. Malaviya R, Georges A. Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin Rev Allergy Immunol 22: 189-204, 2002.
42. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 4: 787-799, 2004.
43. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 114: 21-27, 2004.
44. Marshall JS, King CA, McCurdy JD. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des 9: 11-24, 2003.
45. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev 173: 131-140, 2000.
46. Micklefield G, Konig W, Pfeiffer P, Bohn A. Interaction of monoclonal antibodies with the IgE-receptor on rat mast cells and rat basophilic leukemia (RBL) cells. Agents Actions 17: 418-426, 1986.
47. Migally NB, Tucker A, Greenlees K, Wright M, Zambernard J. Density and ultrastructure of mast cells in lung vessels of aging rats exposed to and recovering from chronic hypoxia. Cell Tissue Res 232: 601-608, 1983.
48. Mislin H. [The contractile properties of lymphatic vessels.] Angiologica 8: 207-211, 1971.
49. Mousli M, Bronner C, Bueb JL, Tschirhart E, Gies JP, Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharmacol Exp Ther 250: 329-335, 1989.
50. Nadon NL. Maintaining aged rodents for biogerontology research. Lab Anim (NY) 33: 36-41, 2004.
51. Nagai T, Bridenbaugh EA, Gashev AA. Aging-associated alterations in contractility of rat mesenteric lymphatic vessels. Microcirculation 18: 463-473, 2011.
52. Nomellini V, Gomez CR, Kovacs EJ. Aging and impairment of innate immunity. Contrib Microbiol 15: 188-205, 2008.
53. Ohhashi T, Kawai Y, Azuma T. The response of lymphatic smooth muscles to vasoactive substances. Pflügers Arch 375: 183-188, 1978.
54. Orlov R, Lobov G. [Ionic mechanisms of the electrical activity of the smooth-muscle cells of the lymphatic vessels.] Fiziol Zh SSSR Im I M Sechenova 70: 712-721, 1984.
55. Pan'kova MN, Lobov GI, Chikhman VN, Solnyshkin SD. [Effects of histamine on contractile activity of lymphatic node capsules. The NO role.] Ross Fiziol Zh I M Sechenova 97: 633-640, 2011.
56. Petunov SG, Egorova AA, Orlov RS, Nikitina ER. Effect of histamine on spontaneous contractions of mesenteric lymphatic vessels and lymph nodes of white rats: endothelium-dependent responses. Dokl Biol Sci 432: 176-180, 2010.
57. Pietrzak A, Wierzbicki M, Wiktorska M, Brzezinska-Blaszczyk E. Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm 2011: 427473, 2011.
58. Plaku KJ, von der Weid PY. Mast cell degranulation alters lymphatic contractile activity through action of histamine. Microcirculation 13: 219-227, 2006.
59. 2 and histamine activate human eosinophils. J Immunol 148: 3536-3542, 1992.
60. Ramos CD, Heluy-Neto NE, Ribeiro RA, Ferreira SH, Cunha FQ. Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1. Cytokine 21: 214-223, 2003.
61. Schueller E, Peutsch M, Bohacek LG, Gupta RK. A simplified toluidine blue stain for mast cells. Can J Med Technol 29: 137-138, 1967.
62. Shepherd RK, Duling BR. Use of Ruthenium Red staining to detect mast cell degranulation in vivo. Microcirculation 2: 363-370, 1995.
63. Singleton EM, Clark SL Jr. The response of mast cells to compound 48/80 studied with the electron microscope. Lab Invest 14: 1744-1763, 1965.
64. Sinzinger H, Kaliman J, Mannheimer E. Regulation of human lymph contractility by prostaglandins and thromboxane. Lymphology 17: 43-45, 1984.
65. Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity 24: 491-494, 2006.
66. Steiner DR, Gonzalez NC, Wood JG. Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 94: 325-334, 2003.
67. Tharp MD, Seelig LL Jr, Tigelaar RE, Bergstresser PR. Conjugated avidin binds to mast cell granules. J Histochem Cytochem 33: 27-32, 1985.
68. Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD, Hart RW. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci 54: B492-B501, 1999.
69. Unthank JL, Hogan RD. The effect of vasoactive agents on the contractions of the initial lymphatics of the bat's wing. Blood Vessels 24: 31-44, 1987.
70. Watanabe N, Kawai Y, Ohhashi T. Dual effects of histamine on spontaneous activity in isolated bovine mesenteric lymphatics. Microvasc Res 36: 239-249, 1988.
71. Wilhelm DL, Yong LC, Watkins SG. The mast cell: distribution and maturation in the rat. Agents and Actions 8: 146-152, 1978.
72. Wu J, Chase JD, Zhu Z, Holzapfel TP. Temperature rise in a tissuemimicking material generated by unfocused and focused ultrasonic transducers. Ultrasound Med Biol 18: 495-512, 1992.
73. Wu L, Feng BS, He SH, Zheng PY, Croitoru K, Yang PC. Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2. Immunol Cell Biol 85: 538-545, 2007.
74. Yong LC, Watkins S, Wilhelm DL. The mast cell: distribution and maturation in the peritoneal cavity of the adult rat. Pathology 7: 307-318, 1975.
75. Yong LC, Watkins SG, Wilhelm DL. The mast cell: II. Distribution and maturaiton in the peritoneal cavity of the young rat. Pathology 9: 221-232, 1977.